The Radiotherapeutic Factors Associated with Reduced Risk of Progression in Patients with Oligometastatic Non-Small Cell Lung Cancer Treated with Local Ablative Radiotherapy

被引：0
|
作者：
Yang, G. [1 ]
Kim, K. H. [1 ]
Lee, C. G., Jr. [1 ]
Yoon, H. I. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2910
引用
收藏
页码：E408 / E408
页数：1
相关论文
共 50 条
  • [21] Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis
    Rim, Chai Hong
    Cho, Won Kyung
    Park, Sunmin
    Yoon, Won Sup
    Yang, Dae Sik
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 1006 - 1014
  • [22] Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma
    Yang, Gowoon
    Kim, Kyung Hwan
    Lee, Chang Geol
    Hong, Min Hee
    Kim, Hye Ryun
    Cho, Yeona
    Yoon, Hong In
    CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 115 - 124
  • [23] Risk Factors for Noncancer Progression-Associated Death in Patients With Non-Small Cell Lung Cancer
    Kong, F. M.
    Campbell, J.
    Jin, J. Y.
    Jolly, S.
    Owen, D.
    Wang, W.
    Kalemkerian, G. P.
    Lawrence, T. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E487 - E488
  • [24] Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
    Sundahl, Nora
    Lievens, Yolande
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3420 - 3431
  • [25] Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis
    Lee, Hye In
    Choi, Eun Kyung
    Kim, Su Ssan
    Shin, Young Seob
    Park, Junhee
    Choi, Chang-Min
    Yoon, Shinkyo
    Kim, Hyeong Ryul
    Cho, Young Hyun
    Song, Si Yeol
    International Journal of Radiation Oncology Biology Physics, 120 (03): : 698 - 707
  • [26] Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer A Recursive Partitioning Analysis
    Lee, Hye In
    Choi, Eun Kyung
    Kim, Su Ssan
    Shin, Young Seob
    Park, Junhee
    Choi, Chang-Min
    Yoon, Shinkyo
    Kim, Hyeong Ryul
    Cho, Young Hyun
    Song, Si Yeol
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (03): : 698 - 707
  • [27] Clarifying oligometastatic non-small cell lung cancer in patients with local ablative therapies for oligoprogression after tyrosine kinase inhibitors
    Hyun, D.
    Jang, Y. J.
    Ji, W.
    Choi, C.
    Lee, D. H.
    Kim, S.
    Yoon, S.
    Kim, W. S.
    Lee, J. C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [28] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [29] Patient, tumour, and dosimetric factors influencing survival in non-small cell lung cancer patients treated with stereotactic ablative body radiotherapy
    Padden-Modi, Minal
    Spivak, Yevhen
    Gleeson, Ian
    Robinson, Andrew
    Jayaprakash, Kamalram Thippu
    BJR OPEN, 2024, 6 (01):
  • [30] Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer
    Yano, Tokujiro
    Okamoto, Tatsuro
    Haro, Akira
    Fukuyama, Seiichi
    Yoshida, Tsukihisa
    Kohno, Mikihiro
    Maehara, Yoshihiko
    LUNG CANCER, 2013, 82 (03) : 431 - 435
12345